DexCom
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of DexCom generated cash of $748,500,000, which is more than the previous year. Cash used in financing activities reached the amount of -$318,600,000 last year. Net change in cash is therefore -$75,800,000.
Cash Flow
| 2014 | 23.6M | -16.8M | 21.8M |
|---|---|---|---|
| 2015 | 49M | -51.5M | 16.8M |
| 2016 | 56.2M | -55.9M | 8.1M |
| 2017 | 92M | -144.4M | 399.1M |
| 2018 | 123.2M | -139.8M | 710.4M |
| 2019 | 314.5M | -1.01B | 10.7M |
| 2020 | 475.6M | -1.01B | 912.1M |
| 2021 | 442.5M | -216.1M | 10.4M |
| 2022 | 669.5M | -521.5M | -552.5M |
| 2023 | 748.5M | -507.2M | -318.6M |
DXCM Cash Flow Statement (2014 β 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 643.3M | 1.05B | 818.2M | 446.4M | 1.13B | 441.5M | 94.5M | 86.1M | 71.8M | 43.2M |
Operating activities | ||||||||||
Net income | 541.5M | 341.2M | 154.7M | 493.6M | 101.1M | -127.1M | -50.2M | -65.6M | -57.6M | -22.4M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 186M | 155.9M | 102M | 67.1M | 48.7M | 29.1M | 16.1M | 15M | 10.8M | 8.4M |
Stock-based compensation expense | 150.8M | 126.5M | 113.4M | 119.4M | 102.7M | 0 | 106.2M | 110.8M | 82.7M | 50M |
| Deferred income tax benefit | 150.8M | 126.5M | 113.4M | 119.4M | 102.7M | 0 | 106.2M | 110.8M | 82.7M | 50M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | -199.9M | -75.5M | -142.3M | -60M | -93.2M | -31.8M | -27.2M | -31.7M | -16.3M |
Inventories | 0 | 49.3M | -112.2M | -114.5M | -49.1M | -25.5M | 400K | -9.8M | -19.2M | -7M |
Accounts payable | 466.5M | 295.1M | 58M | 194.5M | 109M | 56.2M | 21.1M | 21.1M | 17.8M | 8.3M |
Cash generated by operating activities | 748.5M | 669.5M | 442.5M | 475.6M | 314.5M | 123.2M | 92M | 56.2M | 49M | 23.6M |
Investing activities | ||||||||||
Purchases Of Investments | -3.20B | -2.26B | -2.47B | -3.05B | -2.03B | -453.5M | -171.8M | -39.2M | -45.2M | -13.8M |
Investments In Property Plant And Equipment | -236.6M | -364.8M | -389.2M | -199M | -180M | -67.1M | -66M | -55.7M | -33.3M | -16.2M |
Acquisitions Net | 0 | -3.9M | -30.2M | 0 | 835.2M | -11.3M | 0 | 300K | -500K | 0 |
Cash generated by investing activities | -507.2M | -521.5M | -216.1M | -1.01B | -1.01B | -139.8M | -144.4M | -55.9M | -51.5M | -16.8M |
Financing activities | ||||||||||
Common Stock Issued | 26.6M | 22.5M | 20.3M | 15.3M | 11.9M | 10.8M | 10.1M | 10.4M | 19.1M | 24M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -688.7M | -557.7M | 0 | 0 | 0 | -100M | 0 | 0 | 0 | 0 |
Repayments of term debt | 443.3M | 0 | 0 | -282.6M | 0 | -836.6M | 389M | -2.3M | -2.3M | -2.2M |
Cash used in financing activities | -318.6M | -552.5M | 10.4M | 912.1M | 10.7M | 710.4M | 399.1M | 8.1M | 16.8M | 21.8M |
Net Change In Cash | -75.8M | -410.3M | 235.4M | 371.8M | -690.7M | 695.6M | 347M | 8.4M | 14.3M | 28.6M |
Cash at end of period | 567.5M | 643.3M | 1.05B | 818.2M | 446.4M | 1.13B | 441.5M | 94.5M | 86.1M | 71.8M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |